Skip to main content
Fig. 6. | Orphanet Journal of Rare Diseases

Fig. 6.

From: Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan

Fig. 6.

6-year change in HAM-BDSS in patients with HAM-BDSG 0–I. Mean (SD) HAM-BDSS in patients who remained at HAM-BDSG 0 or I throughout the 6-year follow-up (n = 129). During follow-up, changes in HAM-BDSS were statistically significant (repeated measures analysis of variance: p < 0.001 for total and storage symptom scores; p = 0.008 for voiding symptom score). P values in the graph reflect the statistical significance of changes from the third to the fourth year analyzed using paired t-test. HAM-BDSG, HAM/TSP-bladder dysfunction severity grade; HAM-BDSS, HAM/TSP-bladder dysfunction symptom score

Back to article page